TritonPoint Partners »

Immix Biopharma shares owned by TritonPoint Partners

Quarter-by-quarter ownership of Immix Biopharma (IMMX) shares owned by TritonPoint Partners from 13F filings

Historical chart of TritonPoint Partners investment in Immix Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Immix Biopharma held by TritonPoint Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immix Biopharma by TritonPoint Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $223k 25k 9.11

More positions owned by TritonPoint Partners

Spdr Series Trust State Street Spd (BIL)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr Series Trust State Street Spd (SPYG)
Microsoft Corporation (MSFT)
Blackrock Etf Trust Ii Ishares Flexible (BINC)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Spdr Series Trust State Street Spd (SPYV)
Ishares Tr Hdg Msci Eafe (HEFA)
Ishares Tr Core Us Aggbd Et (AGG)

View all positions for TritonPoint Partners

Top funds holding Immix Biopharma

Saturn V Capital Management
Eventide Asset Management
Marshall Wace
Millennium Management
Adage Capital Partners GP
Vanguard Group
Bleichroeder
Logos Global Management
Blue Owl Capital Holdings
Franklin Resources
Susquehanna International
Ameriprise Financial
LGT Fund Management
Perceptive Advisors
Burkehill Global Management

View all funds holding Immix Biopharma